FDA inspection
Aurolife Pharma, LLC: FDA inspection ending Dec 20, 2018
FDA inspection 1076524 · No Action Indicated (NAI) · East Windsor, NJ
Key facts
| Inspection ID | 1076524 |
|---|---|
| Firm | Aurolife Pharma, LLC |
| FEI number | 3014026025 |
| Address | 203 Windsor Center, Suite Iii |
| City | East Windsor |
| State | NJ |
| ZIP | 8520 |
| Fiscal year | 2019 |
| Inspection end date | Dec 20, 2018 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data